Rothschild Investment Corp Bluebird Bio, Inc. Transaction History

Rothschild Investment Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$27.5 - $37.92 $176,192 - $242,953	-6,407 Closed	0 $0
Q3 2020 Oct 22, 2020	SELL	$34.44 - $43.75 $42,189 - $53,593	-1,225 Reduced 16.05%	6,407 $346,000
Q2 2020 Jul 24, 2020	SELL	$27.12 - $45.97 $6,834 - $11,584	-252 Reduced 3.2%	7,632 $466,000
Q1 2020 Apr 16, 2020	SELL	$26.16 - $63.5 $7,194 - $17,462	-275 Reduced 3.37%	7,884 $362,000
Q4 2019 Jan 22, 2020	SELL	$46.96 - $61.67 $11,740 - $15,417	-250 Reduced 2.97%	8,159 $716,000
Q3 2019 Oct 11, 2019	SELL	$59.47 - $93.1 $18,435 - $28,861	-310 Reduced 3.56%	8,409 $772,000
Q2 2019 Jul 11, 2019	BUY	$75.84 - $105.21 $30,336 - $42,084	400 Added 4.81%	8,719 $1.11 Million
Q1 2019 Apr 18, 2019	BUY	$64.44 - $104.11 $163,033 - $263,398	2,530 Added 43.7%	8,319 $1.31 Million
Q4 2018 Jan 28, 2019	SELL	$59.1 - $93.26 $44,384 - $70,038	-751 Reduced 11.48%	5,789 $574,000
Q2 2018 Jul 24, 2018	BUY	$99.64 - $127.59 $95,654 - $122,486	960 Added 17.2%	6,540 $1.03 Million
Q1 2018 Apr 27, 2018	SELL	$105.8 - $150.94 $594,067 - $847,528	-5,615 Reduced 50.16%	5,580 $953,000
Q4 2017 Jan 23, 2018	BUY	$81.25 - $130.7 $909,593 - $1.46 Million	11,195	11,195 $1.99 Million

144

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $644M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

Stay updated on Rothschild Investment Corp with notifications on news.